Search Results - "Robella, M."

Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI) by Lo Dico, R., Faron, M., Yonemura, Y., Glehen, O., Pocard, M., Sardi, A., Hübner, M., Baratti, D., Liberale, G., Kartheuser, A., de Hingh, I., Sugarbaker, P., Ceelen, W., Moran, B., Robella, M., Quenet, F., Sideris, L., Goere, D., Limbert, M., Sammartino, P., Morris, D., Abba, J., Abboud, K., Arvieux, C., Carrere, S., Facy, O., Ferron, G., Lorimier, G., Marchal, F., Rat, P., Tuech, J.-J., Villeneuve, Laurent, Ortega-Deballon, P.

Get full text

323. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Risk factors for morbidity and postoperative outcome by Robella, M, Vaira, M, De Simone, M

Get full text

358. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: An innovative approach for peritoneal carcinomatosis by Robella, M, Vaira, M, De Simone, M

Get full text

359. Single – Port access for pressurized intraperitoneal aerosol chemotherapy (PIPAC): Technique, feasibility and safety by Vaira, M, Robella, M, De Simone, M

Get full text

PIPAC nebulizer: How to test the new devices in the market, expert recommendations by Pocard, M., So, J.B.Y., Huchon, C., Robella, M., Chavatte-Palmer, P., Eveno, C., Glehen, O., Peng Yong, W.

“…Pressurized intraperitoneal aerosol chemotherapy, named PIPAC, is now used in many centers around the world and as an intraperitoneal drug delivery system for…”
Get full text

Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) by Vaira, M, Robella, M, Cinquegrana, A, De Simone, M

Get full text

Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hipec: Results in highly selected patients by Vaira, M, Robella, M, Cinquegrana, A, De Simone, M

Get full text

58. Central motor conduction time along the phrenic nerve pathway and fiber tracking in Chiari and Syringomyelia by Ciaramitaro, P, Ferraris, M, Spagone, E, Giorgi, S, Peci, E, Audisio, A, Curreri, L, Robella, M, Valentini, M.C, Cocito, d

“…Cortico-diaphragmatic pathway was investigated with transcranial magnetic stimulation (TMS) in amyotrophic lateral sclerosis without clinical signs of…”
Get full text

47. Histological, biochemical and transcriptional classification of pseudomyxoma peritonei can solve the uncertainty of predicting outcome? by Vaira, M, Robella, M, Picco, G, Bellomo, S.E, Medico, E, De Simone, M

Get full text

Prognostic value of specific KRAS mutations in patients with colorectal peritoneal metastases by Tonello, M., Baratti, D., Sammartino, P., Di Giorgio, A., Robella, M., Sassaroli, C., Framarini, M., Valle, M., Macrì, A., Graziosi, L., Coccolini, F., Lippolis, P.V., Gelmini, R., Deraco, M., Biacchi, D., Aulicino, M., Vaira, M., De Franciscis, S., D’Acapito, F., Carboni, F., Milone, E., Donini, A., Fugazzola, P., Faviana, P., Sorrentino, L., Pizzolato, E., Cenzi, C., Del Bianco, P., Sommariva, A.

“…There is little evidence on KRAS mutational profiles in colorectal cancer (CRC) peritoneal metastases (PM). This study aims to determine the prevalence of…”
Get full text

Histological, biochemical and transcriptional classification of Pseudomyxoma Peritonei (PMP) can solve the uncertainty of predicting outcome? by Robella, M, Vaira, M, Picco, G, Bellomo, S, Borsano, A, Porporato, R, Medico, E, De Simone, M

Get full text

Contamination risk for operators performing semi-closed HIPEC procedure using cisplatin by Caneparo, A, Massucco, P, Vaira, M, Maina, G, Giovale, E, Coggiola, M, Cinquegrana, A, Robella, M, De Simone, M

“…Abstract Aims Aim of this study was to assess operators' safety while performing a semi-closed HIPEC procedure for peritoneal carcinomatosis using cisplatin…”
Get full text

Total mesorectal excision by transanal approach: Preliminary results by Marsanic, P, Mellano, A, Robella, M, Vaira, M, De Simone, M, Muratore, A

Get full text

Explorative laparoscopy in peritoneal malignancies staging: A useful tool to predict suitability for complete cytoreductive surgery by Vaira, M, Robella, M, Mellano, A, Marsanic, P, De Simone, M

Get full text

Risk factors for morbidity and postoperative outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. A single – center experience by Robella, M, Vaira, M, Mellano, A, Cinquegrana, A, Marsanic, P, De Simone, M

Get full text

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal carcinomatosis: The impact of patients' selection policy on outcome and morbidity by Vaira, M, Robella, M, Massucco, P, Cinquegrana, A, De Simone, M

Get full text

Treatment of pseudomyxoma peritonei with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): A single center experience by Robella, M, Vaira, M, Mellano, A, Cinquegrana, A, Marsanic, P, De Simone, M

Get full text

Secondary cytoreductive surgery, hyperthermic intraperitoneal intraoperative chemotherapy, and chemotherapy alone: a retrospective comparison of alternative approaches in relapsed platinum sensitive ovarian cancer by Marocco, F, Vaira, M, Milani, A, Genta, S, Maggiorotto, F, Magistris, A, Cinquegrana, A, Robella, M, De Simone, M, Aglietta, M, Ponzone, R, Valabrega, G

“…The best treatment for relapsed platinum sensitive epithelial ovarian cancer (EOC) is controversial. The aim of the study was to compare progression-free…”
Get more information

Management of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery+HIPEC by Vaira, M, Massucco, P, Robella, M, Cinquegrana, A, Mellano, A, De Simone, M

Get full text

Pelvic evisceration for pelvic neoplastic disease: Our results by Siatis, D, Mellano, A, Robella, M, Barbera, M, Maucioni, G, De Simone, M

Get full text